| Followers | 5 |
| Posts | 83 |
| Boards Moderated | 0 |
| Alias Born | 06/14/2020 |
Thursday, June 25, 2020 1:06:01 AM
I think it is beyond obvious that Brilacidin reducing the viral load in its contained. Separate little petri dish is outstanding. ..in comparison to what... doesn't matter in preclinical trials.
The grant money for clinical trials is when the comparison counts in phase 3 because that is a comparison between the new drug candidate , Briacidin and the " standard of care" drug. Only there doesn't at present seem to be a "standard" drug to fight Covid 19.
From
https://www.nccn.org/patients/resources/clinical_trials/phases.aspx
Phase III
Phase III trials compare a new drug to the standard-of-care drug. These trials assess the side effects of each drug and which drug works better. Phase III trials enroll 100 or more patients.
Phase 0 thru 2 is about safety and side effects. Phase 3 begs the question "in comparison to what?".
You seem to be insinuating that unless there is more specificity about whether the other covid 19 sample was in tap water. Saline, Dr. Pepper, some stupidly expensive inert foam or whatever,, etc..that somehow the results are suspect, which is false. We don't even need to know that. All we need to know is that if left alone, not falsely accused and not mixed with other strange stuff in the same dish, B killed 97% of the Covid 19 in the dish. For all we know the only reason it didn't kill 100 percent is that the dead little bodies of the Covid 19 dudes created a surface area around the survivors thus impeding contact with the rest and that with 3 dimensions to work in it might get 100 %.
You seem to like pseudo intellectual scientific jargon mingled with math for that look smart reading material. But that stuff just confuses you into worthless questions.
I gave it to you straight, with some emotional ques and a few numbers. Good?
I hope the stock price goes down so I can buy more shares cheaper..before it goes up again. There, I said it. But I'm not going to try and force it down with insinuations against the very company that is working night and day to save lives and make me wealthy in the process.
The grant money for clinical trials is when the comparison counts in phase 3 because that is a comparison between the new drug candidate , Briacidin and the " standard of care" drug. Only there doesn't at present seem to be a "standard" drug to fight Covid 19.
From
https://www.nccn.org/patients/resources/clinical_trials/phases.aspx
Phase III
Phase III trials compare a new drug to the standard-of-care drug. These trials assess the side effects of each drug and which drug works better. Phase III trials enroll 100 or more patients.
Phase 0 thru 2 is about safety and side effects. Phase 3 begs the question "in comparison to what?".
You seem to be insinuating that unless there is more specificity about whether the other covid 19 sample was in tap water. Saline, Dr. Pepper, some stupidly expensive inert foam or whatever,, etc..that somehow the results are suspect, which is false. We don't even need to know that. All we need to know is that if left alone, not falsely accused and not mixed with other strange stuff in the same dish, B killed 97% of the Covid 19 in the dish. For all we know the only reason it didn't kill 100 percent is that the dead little bodies of the Covid 19 dudes created a surface area around the survivors thus impeding contact with the rest and that with 3 dimensions to work in it might get 100 %.
You seem to like pseudo intellectual scientific jargon mingled with math for that look smart reading material. But that stuff just confuses you into worthless questions.
I gave it to you straight, with some emotional ques and a few numbers. Good?
I hope the stock price goes down so I can buy more shares cheaper..before it goes up again. There, I said it. But I'm not going to try and force it down with insinuations against the very company that is working night and day to save lives and make me wealthy in the process.
